as on September 18, 2025 at 4:01 pm IST
Market Cap
₹589.78 Cr
Return on Equity (ROE)
14.34
PE Ratio (TTM)
0Return on capital employed (ROCE)
16.95
Beta (LTM)
0.44
P/B Ratio
2.81
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
63.92
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Fredun Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 589.78 | 87.66% | 0.00 | 15 | 348 | |
NA | 323.06 | 12.17% | 0.00 | 10 | 150 | |
BUY | 11,519.78 | 5.09% | 0.00 | 485 | 2,386 | |
NA | 1,315.39 | 2290.77% | 0.00 | 9 | 32 | |
NA | 836.28 | -5.52% | 0.61 | 21 | 368 |
Search interest for Fredun Pharmaceuticals Ltd Stock has increased by 63% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:63% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Fredun Pharmaceuticals Ltd.
Fredun Pharmaceuticals Ltd’s net profit jumped 63.92% since last year same period to ₹6.77Cr in the Q1 2025-2026. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 12.83% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Fredun Pharmaceuticals Ltd has declared dividend of ₹0.70 per share on 07 May 2024 - translating a dividend yield of 0.11%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, Fredun Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 1 month, Fredun Pharma stock has moved up by 18.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 48.93% of holdings in Jun 2025 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 49.48% of holdings in Jun 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.7% return, outperforming this stock by 122.5%
Organisation | Fredun Pharmaceuticals Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | Daulat N Medhora |
E-voting on shares | Click here to vote |
Fredun Pharmaceuticals Ltd share price today stands at ₹1250 as on at the close of the market. Fredun Pharmaceuticals Ltd share today touched a day high of ₹1275 and a low of ₹1216.1.
Fredun Pharmaceuticals Ltd touched a 52 week high of ₹1340 and a 52 week low of ₹635. Fredun Pharmaceuticals Ltd share price today i.e. is closed at ₹1250, which is -6.72% down from its 52 week high and 96.85% up from its 52 week low.
Fredun Pharmaceuticals Ltd market capitalisation is ₹589.78 Cr as on .
To buy Fredun Pharmaceuticals Ltd shares, you need to follow these steps:
Fredun Pharmaceuticals Ltd trading volume is 4,408.00 as on . This means that 4,408.00 shares of Fredun Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.